Since mice have a different repertoire of antibodies than humans, murine mAbs have the potential for neutralizing a broader spectrum of SARS-CoV-2 variants than fully human mAbs.

Source: https://forextv.com/top-news/tonix-pharmaceuticals-announces-exclusive-license-of-potential-therapeutic-or-preventative-fully-human-and-murine-anti-sars-cov-2-monoclonal-antibodies/

Since mice have a different repertoire of antibodies than humans, murine mAbs have the potential for neutralizing a broader spectrum of SARS-CoV-2 variants than fully human mAbs.

Source: https://forextv.com/top-news/tonix-pharmaceuticals-announces-exclusive-license-of-potential-therapeutic-or-preventative-fully-human-and-murine-anti-sars-cov-2-monoclonal-antibodies/

The increase in demand for mAbs is notably driving the market growth, although factors such as the shortage of trained professionals may impede the market growth.

Source: https://www.prnewswire.com/news-releases/microbiology-testing-market-to-grow-by-usd-3-01-bn-abbott-laboratories-and-bio-rad-laboratories-inc-among-key-vendors---technavio-301744250.html